Robin Patel, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Research Funding (if you were the principal or named investigator)
    Ineligible company:
    CContraFect, TenNor Therapeutics Limited, APT and BIOFIRE
    Topic:
    Research
    Date added:
    Date updated:
    07/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    PhAST, Torus Biosystems, Day Zero Diagnostics, Mammoth Biosciences, and HealthTrackRx
    Topic:
    Consultant - Monies go to my employer
    Date added:
    Date updated:
    07/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Netflix, Abbott Laboratories, Oxford Nanopore Technologies, and CARB-X
    Topic:
    Consultant
    Date added:
    Date updated:
    07/29/2024
  • Attribution:
    Self
    Type of financial relationship:
    Royalties or Patent Beneficiary
    Ineligible company:
    Dr. Patel has a patent on Bordetella pertussis/parapertussis PCR issued, a patent on a device/method for sonication with royalties paid by Samsung to Mayo Clinic, and a patent on an anti-biofilm substance issued
    Date added:
    Date updated:
    07/29/2024
  • Type of financial relationship:
    Consultant
    Ineligible company:
    Pathogenomix
    Date added:
    04/05/2022
    Date updated:
    07/29/2024
Return to 2024 Infectious Disease Board Review Course